Correlation between EEG characteristics and neuropeptide Y and epilepsy risk after acute stroke
-
摘要:
目的 探讨脑电图特征和神经肽Y水平对急性脑卒中后癫痫发生风险的影响，并对相关因素进行分析。 方法 选取2021年3月—2022年3月湖州市第一人民医院收治的46例急性脑卒中后癫痫患者作为癫痫组，再选取同期接受治疗的43例急性脑卒中后非癫痫患者作为非癫痫组。所有受试者均给予至少2 h的脑电图监测，并检测其神经肽Y水平，分析神经肽Y水平和脑电图特征与急性脑卒中后癫痫的相关性。 结果 癫痫组患者慢波指数、脑对称指数(BSI)及脑电图慢波化比率(DTABR)均高于非癫痫组(P < 0.05)；癫痫组患者神经肽Y水平低于非癫痫组，神经元特异烯醇化酶(NSE)、同型半胱氨酸(Hcy)及超敏C反应蛋白(hs-CRP)水平均高于非癫痫组(P < 0.05)。多因素logistic回归分析显示，神经肽Y(OR=0.671)、NSE(OR=1.174)水平、慢波指数(OR=1.124)以及BSI(OR=1.344)均是急性脑卒中后癫痫发生的独立影响因素(P < 0.05)。ROC曲线显示，神经肽Y、慢波指数及BSI联合预测急性脑卒中后癫痫发生的效能最高，其AUC为0.976，灵敏度为93.48%，特异度为97.67%。 结论 脑电图特征的异常改变和神经肽Y水平的降低是导致急性脑卒中后癫痫发生的危险因素，神经肽Y水平和脑电图特征可用于预测急性脑卒中后癫痫。 Abstract:Objective To explore the influence of EEG characteristics and neuropeptide Y level on the risk of epilepsy after acute stroke, and analyze the related factors. Methods A total of 46 patients with epilepsy after acute stroke treated in Huzhou First People' s Hospital from March 2021 to March 2022 were selected as the research object, and 43 patients with non-epilepsy after acute stroke treated in the same period were selected as the observation control. All subjects were given EEG monitoring for at least 2 hours, and their neuropeptide Y levels were detected, and the correlation between their levels and EEG characteristics and the progress of epilepsy after acute stroke was analyzed. Results Slow wave index, BSI, and DTABR in the epileptic group were higher than those in the non-epileptic group (P < 0.05). The levels of neuropeptide Y in the epileptic group were lower than those in the non-epileptic group, and the levels of NSE, Hcy, and hs-CRP were higher than those in the non-epileptic group (P < 0.05). Multivariate logistic regression analysis showed that neuropeptide Y (OR=0.671), NSE (OR=1.174), slow wave index (OR=1.124), and BSI (OR=1.344) were independent risk factors for epilepsy after acute stroke (P < 0.05). ROC curve showed that the combined prediction of neuropeptide Y, slow wave index and BSI has the highest prediction efficiency, with AUC of 0.976, sensitivity of 93.48%, and specificity of 97.67%. Conclusion Abnormal changes in EEG characteristics and the decrease of neuropeptide Y level are risk factors for epilepsy after acute stroke. Neuropeptide Y level and EEG characteristics can be used to prevent and treat epilepsy after acute stroke. -
Key words:
- Epilepsy after stroke /
- Electroencephalogram /
- Serum neuropeptide Y /
- Ischemic stroke /
- Risk factor /
- Correlation
-
表 1 2组急性脑卒中患者一般资料比较
Table 1. Comparison of general data between two groups of patients with acute stroke
项目 癫痫组(n=46) 非癫痫组(n=43) 统计量 P值 年龄(x±s，岁) 68.25±6.48 69.37±7.63 0.744a 0.459 性别[例(%)] 0.835b 0.361 男性 29(63.04) 23(53.49) 女性 17(36.96) 20(46.51) 病程(x±s，月) 4.85±1.37 5.03±1.54 0.581a 0.563 病灶部位[例(%)] 4.861b 0.027 大脑皮质 31(67.39) 19(44.19) 其他 15(32.61) 24(55.81) 病变偏侧[例(%)] 0.252b 0.882 左侧 18(39.13) 15(34.88) 右侧 19(41.30) 18(41.86) 双侧 9(19.57) 10(23.26) 吸烟史[例(%)] 15(32.61) 13(30.23) 0.058b 0.809 饮酒史[例(%)] 11(23.91) 9(20.93) 0.113b 0.736 家族癫痫史[例(%)] 4(8.70) 2(4.65) 0.578b 0.447 基础病史[例(%)] 高血压 23(50.00) 17(39.53) 0.984b 0.321 糖尿病 9(19.57) 7(16.28) 0.163b 0.687 高血脂 8(17.39) 10(23.26) 0.474b 0.491 冠心病 11(23.91) 13(30.23) 0.451b 0.502 NIHSS评分(x±s，分) 13.25±2.63 11.81±3.12 2.346a 0.021 注：a为t值，b为χ2值。 
下载: 导出CSV
表 2 2组急性脑卒中患者血液检查指标和脑电图特征比较(x±s)
Table 2. characteristics between two groups of acute stroke patients (x±s)
项目 癫痫组
(n=46)非癫痫组
(n=43)t值 P值 血液检查指标 神经肽Y(ng/mL) 86.15±8.87 108.15±9.22 11.457 ＜0.001 NSE(μg/L) 24.98±3.09 20.58±4.06 5.724 ＜0.001 Hcy(μmol/L) 14.85±3.76 12.05±2.45 4.188 ＜0.001 hs-CRP(mg/L) 3.06±0.77 2.64±0.81 2.503 0.014 脑电图特征 慢波指数 1.63±0.21 1.16±0.15 12.209 ＜0.001 BSI 0.43±0.09 0.17±0.04 17.803 ＜0.001 DTABR 10.31±2.15 8.26±1.55 5.184 ＜0.001
下载: 导出CSV
表 3 急性脑卒中后癫痫发生的单因素logistic回归分析
Table 3. Univariate logistic regression analysis of post-stroke epilepsy
变量 B SE Waldχ2 P值 OR值 95% CI 病灶部位 0.960 0.440 4.765 0.029 2.611 1.103~6.179 NIHSS评分 0.218 0.084 6.773 0.009 1.243 1.055~1.465 神经肽Y -0.265 0.059 20.440 < 0.001 0.767 0.684~0.860 NSE 0.102 0.029 12.146 < 0.001 1.107 1.046~1.172 Hcy 0.203 0.074 7.579 0.006 1.225 1.060~1.415 hs-CRP 0.476 0.103 21.266 < 0.001 1.609 1.315~1.970 慢波指数 0.136 0.028 23.389 < 0.001 1.146 1.084~1.211 BSI 0.334 0.073 21.102 < 0.001 1.396 1.211~1.610 DTABR 0.048 0.019 6.275 0.012 1.050 1.011~1.090
下载: 导出CSV
表 4 急性脑卒中后癫痫发生的多因素logistic回归分析
Table 4. Multivariate logistic regression analysis of post-stroke epilepsy
变量 B SE Waldχ2 P值 OR值 95% CI 病灶部位 2.816 1.754 2.575 0.109 16.702 0.536~520.215 NIHSS评分 0.061 0.215 0.081 0.776 1.063 0.698~1.620 神经肽Y -0.400 0.149 7.203 0.007 0.671 0.501~0.898 NSE 0.161 0.077 4.300 0.038 1.174 1.009~1.367 Hcy 0.276 0.162 2.908 0.088 1.318 0.960~1.809 hs-CRP 0.606 0.332 3.325 0.068 1.832 0.956~3.513 慢波指数 0.117 0.038 9.666 0.002 1.124 1.044~1.210 BSI 0.295 0.107 7.565 0.006 1.344 1.089~1.659 DTABR 0.073 0.050 2.176 0.140 1.076 0.976~1.185
下载: 导出CSV
表 5 脑电图特征和神经肽Y对急性脑卒中后癫痫的预测价值
Table 5. The predictive value of EEG characteristics and neuropeptide Y in post-stroke epilepsy
项目 截断值 AUC 灵敏度
(%)特异度
(%)95% CI Youden指数 神经肽Y 95.03 ng/mL 0.861 79.57 80.70 0.772~0.926 0.603 慢波指数 1.32 0.900 82.61 90.70 0.818~0.953 0.733 BSI 3.31 0.869 77.39 80.02 0.780~0.931 0.604 联合预测 0.976 93.48 97.67 0.919~0.997 0.912
下载: 导出CSV
-
[1] 周罗, 解媛媛, 肖波. 全面认识卒中后癫痫[J]. 中国临床医生杂志, 2021, 49(6): 640-642. doi: 10.3969/j.issn.2095-8552.2021.06.003ZHOU L, XIE Y Y, XIAO B. A comprehensive understanding epilepsy after stroke[J]. Chinese Journal For Clinicians, 2021, 49(6): 640-642. doi: 10.3969/j.issn.2095-8552.2021.06.003 [2] HASSANI M, COORAY G, SVEINSSON O, et al. Post-stroke epilepsy in an ischemic stroke cohort-Incidence and diagnosis[J]. Acta Neurol Scand, 2020, 141(2): 141-147. doi: 10.1111/ane.13174 [3] GALOVIC M, FERREIRA-ATUESTA C, ABRAIRA L, et al. Seizures and epilepsy after stroke: epidemiology, biomarkers and management[J]. Drugs Aging, 2021, 38(4): 285-299. doi: 10.1007/s40266-021-00837-7 [4] DZIADKOWIAK E, GUZIŃSKI M, CHOJDAK-ŁUKASIEWICZ J, et al. Predictive factors in post-stroke epilepsy: retrospective analysis[J]. Adv Clin Exp Med, 2021, 30(1): 29-34. doi: 10.17219/acem/128745 [5] SUN W M, ZHANG Z X, FENG X, et al. Serum Neuropeptide Y: a potential prognostic marker of intracerebral hemorrhage[J]. Dis Markers, 2021, 2021: 7957013. DOI: 10.1155/2021/7957013. [6] DECRESSAC M, BARKER R A. Neuropeptide Y and its role in CNS disease and repair[J]. Exp Neurol, 2012, 238(2): 265-272. doi: 10.1016/j.expneurol.2012.09.004 [7] YEO X Y, CUNLIFFE G, HO R C, et al. Potentials of neuropeptides as therapeutic agents for neurological diseases[J]. Biomedicines, 2022, 10(2): 343. DOI: 10.3390/biomedicines10020343. [8] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. doi: 10.3760/cma.j.issn.1006-7876.2018.09.004Chinese Society of Neurology; Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chinese Journal of Neurology, 2018, 51(9): 666-682. doi: 10.3760/cma.j.issn.1006-7876.2018.09.004 [9] FISHER R S, CROSS J H, D' SOUZA C, et al. Instruction manual for the ILAE 2017 operational classification of seizure types[J]. Epilepsia, 2017, 58(4): 531-542. doi: 10.1111/epi.13671 [10] ALET M, MÁRQUEZ F, MARONE A, et al. Predictive factors for the development of epilepsy after ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2022, 31(12): 106858. DOI: 10.1016/j.jstrokecerebrovasdis.2022.106858. [11] FARIA M T, REGO R, ROCHA H, et al. cTnI, BNP and CRP profiling after seizures in patients with drug-resistant epilepsy[J]. Seizure, 2020, 80: 100-108. doi: 10.1016/j.seizure.2020.06.003 [12] LIU Z Y, LI J M, YANG F, et al. Sodium valproate combined with levetiracetam in pediatric epilepsy and its influence on NSE, IL-6, hs-CRP and electroencephalogram improvement[J]. Exp Ther Med, 2020, 20(3): 2043-2048. [13] SELVAN GNANA SEKARAN T, RICOUL M, BROCHARD P, et al. An alternative approach for the induction of premature chromosome condensation in human peripheral blood lymphocytes using mitotic Akodon cells[J]. Int J Radiat Biol, 2020, 96(2): 214-219. doi: 10.1080/09553002.2019.1625493 [14] 郭娜, 马英, 王琳莹, 等. 脑卒中患者血清Hcy及NSE水平与癫痫发作的相关性研究[J]. 现代检验医学杂志, 2022, 37(1): 177-181. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYN202201036.htmGUO N, MA Y, WANG L Y, et al. Correlation between serum Hcy, NSE levels and epileptic seizures in patients with stroke[J]. Journal of Modern Laboratory Medicine, 2022, 37(1): 177-181. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYN202201036.htm [15] 王洒, 余昊. 血清铜、诱导型一氧化氮合酶与急性缺血性脑卒中患者神经功能缺损及预后的相关性研究[J]. 中华全科医学, 2023, 21(9): 1520-1522. doi: 10.16766/j.cnki.issn.1674-4152.003160WANG S, YU H. Correlation of serum copper and inducible nitric oxide synthase with neurological deficit and prognosis in patients with acute ischemic stroke[J]. Chinese Journal of General Practice, 2023, 21(9): 1520-1522. doi: 10.16766/j.cnki.issn.1674-4152.003160 [16] YANG H J, RAJAH G, GUO A C, et al. Pathogenesis of epileptic seizures and epilepsy after stroke[J]. Neurol Res, 2018, 40(6): 426-432. doi: 10.1080/01616412.2018.1455014 [17] QIU L, ZHANG D L, SANG Y, et al. Relationship between tumor necrosis factor-alpha and neuropeptide Y expression and neurological function score in epileptic children[J]. Iran J Public Health, 2021, 50(5): 1056-1064. [18] 韩秀峰. 银杏达莫注射液联合依达拉奉治疗急性脑出血疗效及对外周血S100B、神经肽Y水平的影响[J]. 医药论坛杂志, 2020, 41(3): 131-133. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202003037.htmHAN X F. Therapeutic effect of Yinxingdamo injection combined with edaravone on acute cerebral hemorrhage and its influence on S100B and neuropeptide Y levels in peripheral blood[J]. Journal of Medical Forum, 2020, 41(3): 131-133. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202003037.htm [19] KRAMER A, KROMM J. What is the role of continuous electroencephalography in acute ischemic stroke and the relevance of the "ictal-interictal continuum"?[J]. Neurocrit Care, 2020, 32(3): 687-690. doi: 10.1007/s12028-020-00945-z [20] 刘秀颖, 蓝瑞芳. 急性缺血性脑卒中定量脑电图特征与CT灌注成像参数的相关性[J]. 上海交通大学学报(医学版), 2021, 41(1): 62-65. https://www.cnki.com.cn/Article/CJFDTOTAL-SHEY202101013.htmLIU X Y, LAN R F. Correlation between quantitative electroencephalogram features and CT perfusion imaging parameters in acute ischemic stroke[J]. Journal of Shanghai Jiao tong University: Medical Science, 2021, 41(1): 62-65. https://www.cnki.com.cn/Article/CJFDTOTAL-SHEY202101013.htm [21] 庞振阳, 刘一尔. 脑卒中后癫痫发作的临床特点和视频脑电图分析[J]. 临床内科杂志, 2020, 37(7): 515-516. doi: 10.3969/j.issn.1001-9057.2020.07.016PANG Z Y, LIU Y E. Clinical features and video electroencephalogram analysis of post-stroke seizures[J]. Journal of Clinical Internal Medicine, 2020, 37(7): 515-516. doi: 10.3969/j.issn.1001-9057.2020.07.016 [22] WICKHAM J, LEDRI M, BENGZON J, et al. Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patients[J]. Sci Rep, 2019, 9(1): 19393. DOI: 10.1038/s41598-019-56062-1. [23] WANG N, WANG D X, ZHOU H, et al. Serum neuropeptide Y level is associated with post-ischemic stroke epilepsy[J]. J Stroke Cerebrovasc Dis, 2021, 30(2): 105475. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105475. [24] DONG W J, LU Y L, ZHAI Y J, et al. Plasma neuropeptide Y and cognitive impairment after acute ischemic stroke[J]. J Affect Disord, 2022, 317: 221-227. doi: 10.1016/j.jad.2022.08.052 [25] PRZYKAZA Ł, KOZNIEWSKA E. Ligands of the neuropeptide Y Y2 receptors as a potential multitarget therapeutic approach for the protection of the neurovascular unit against acute ischemia/reperfusion: view from the perspective of the laboratory bench[J]. Transl Stroke Res, 2022, 13(1): 12-24. doi: 10.1007/s12975-021-00930-4 -
点击查看大图
图(1) / 表(5)
计量
- 文章访问数: 125
- HTML全文浏览量: 91
- PDF下载量: 5
- 被引次数: 0
